EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Cytomegalovirus and Epstein-Barr Virus reactivation in steroid-refractory immune checkpoint inhibitor colitis

Joyce Sanyour, Bassem Awada, Ahmad Mattar, Rasha Matar, Nausheen Yaqoub, Ibrahim Al Haddabi, Khalid Al-Baimani, Issa Qarshoubi

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.21109 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Joyce Sanyour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Division, Internal Medicine Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (U…. Hauptthemen laut MEDLINE: Colitis, Immune Checkpoint Inhibitors, Cytomegalovirus, Cytomegalovirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) reactivation are known complications in immunocompromised hosts, particularly transplant recipients. However, their occurrence and clinical implications in patients with solid tumors remain underexplored. The introduction of immune checkpoint inhibitors (ICIs) has transformed cancer therapy, but immune-related adverse events (irAEs), including colitis, are increasingly recognized. The potential role of viral reactivation in exacerbating these toxicities is not well established. Cases Presentation: We report two cases of patients with solid tumors treated with ICIs who developed severe, refractory immune-related colitis. Extensive evaluation revealed markedly elevated CMV and EBV viral loads in colonic biopsies, confirmed by histopathology. Both patients showed significant clinical and endoscopic improvement following antiviral therapy with ganciclovir, highlighting the role of CMV and EBV in modulating the severity of ICI-induced colitis.

Conclusions

CMV and EBV reactivation may contribute to the persistence or worsening of ICI-induced colitis. Early recognition and treatment of viral reactivation in patients with irAEs may improve outcomes. Clinical judgment and serial viral monitoring are essential for guiding management decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisImmune Checkpoint InhibitorsCytomegalovirusCytomegalovirus InfectionsEpstein-Barr Virus InfectionsHerpesvirus 4, HumanVirus ActivationHumansMaleMiddle AgedAntiviral AgentsFemaleAgedGanciclovirImmunocompromised HostViral Load

Stichwörter der Autor:innen

Cytomegalovirusimmune-checkpoint inhibitorsimmune-related adverse eventsimmune-related colitis

Substanzen

Immune Checkpoint InhibitorsAntiviral AgentsGanciclovir

Autor:innen und Institutionen

  • Gastroenterology Division, Internal Medicine Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.
  • Infectious Diseases Division, Internal Medicine Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.
  • Medical Oncology Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.
  • Histopathology Department, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.
  • Laboratory Medicine, Sultan Qaboos Comprehensive Cancer and Research Center (SQCCCRC), University Medical City (UMC), Muscat, Sultanate of Oman.

Zitieren

APA

Sanyour, J., Awada, B., Mattar, A., Matar, R., Yaqoub, N., Al Haddabi, I., Al-Baimani, K., & Qarshoubi, I. (2025). Cytomegalovirus and Epstein-Barr Virus reactivation in steroid-refractory immune checkpoint inhibitor colitis. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.21109

Vancouver

Sanyour J, Awada B, Mattar A, Matar R, Yaqoub N, Al Haddabi I, et al. Cytomegalovirus and Epstein-Barr Virus reactivation in steroid-refractory immune checkpoint inhibitor colitis. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.21109

BibTeX
@article{Sanyour2025,
  author = {Sanyour, Joyce and Awada, Bassem and Mattar, Ahmad and Matar, Rasha and Yaqoub, Nausheen and Al Haddabi, Ibrahim and Al-Baimani, Khalid and Qarshoubi, Issa},
  title = {Cytomegalovirus and Epstein-Barr Virus reactivation in steroid-refractory immune checkpoint inhibitor colitis},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.21109}
}
Kostenlos starten →